Here’s what you need to know.
1. The trial’s first half focused on whether the merger would hinder competition in national markets.
2. WBAA spoke to Saint Louis University antitrust specialist Tim Greaney. Mr. Greaney said the Department of Justice has submitted ample evidence to prove the two companies are competing for national insurance contracts.
Mr. Greaney sees Cigna as a smaller force, undercutting Anthem and keeping the larger company “on its toes.”
3. If the federal judge finds the arguments from the DOJ convincing enough, she could indefinitely postpone the second half of the trial, which would examine the merger’s effect on small markets.
More articles on coding, billing and collections:
Best practices for coding & billing 4 common GYN procedures
Columnist: Health industry lobbies to keep ACA customers — 4 takeaways
Pelosi: Democrats don’t support Medicare, VA privatization
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
